Climb Bio, Inc. CLYM Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s additional paid-in capital?
- Climb Bio, Inc. (CLYM) reported additional paid-in capital of $451.37M in Q1 2026.
- How has Climb Bio, Inc.'s additional paid-in capital changed year-over-year?
- Climb Bio, Inc.'s additional paid-in capital increased by 1.7% year-over-year, from $443.75M to $451.37M.
- What is the long-term trend for Climb Bio, Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s additional paid-in capital has grown at a 169.7% compound annual growth rate (CAGR), from $3.15M to $449.76M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.